Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

568
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
568
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

990
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
990
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

408
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
408
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

375
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
375
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

238
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
238
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

463
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
463

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of a Dementia Diagnosis in Community-Dwelling Older Adults With Normal MMSE Scores in the United States.

American journal of medicine open·2026
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Plasma Biomarkers for Cerebral Amyloid Angiopathy and Implications for Amyloid-Related Imaging Abnormalities: A Comprehensive Review.

Journal of clinical medicine·2025
Same author

Associations of late-life blood pressure with CERAD, Braak, and Thal: Findings from the National Alzheimer's coordinating center neuropathology dataset.

Neuropathology : official journal of the Japanese Society of Neuropathology·2025
Same author

Lower Risk of Death and Kidney Failure Associated with Higher Target (vs Below-Target) Doses of RAS Inhibitors in Octogenarians with HFrEF.

The American journal of medicine·2024
Same author

Cerebral Amyloid Angiopathy, Dementia, and Alzheimer Neuropathologic Changes: Findings From the ACT Autopsy Cohort.

Neurology·2024

Related Experiment Video

Updated: Oct 25, 2025

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

2.1K

Constipation Management in Parkinson Disease.

Molly Cheesman, Haily Ho, Krista Bishop

    The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses
    |August 9, 2021
    PubMed
    Summary
    This summary is machine-generated.

    Constipation is a common early symptom of Parkinson disease (PD), often appearing years before motor issues. Early management combining lifestyle changes and medication improves patient outcomes.

    More Related Videos

    Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
    03:50

    Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

    Published on: August 18, 2023

    2.2K
    Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
    04:04

    Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

    Published on: July 5, 2024

    655

    Related Experiment Videos

    Last Updated: Oct 25, 2025

    Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
    03:20

    Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

    Published on: September 22, 2023

    2.1K
    Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
    03:50

    Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

    Published on: August 18, 2023

    2.2K
    Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
    04:04

    Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

    Published on: July 5, 2024

    655

    Area of Science:

    • Neurology
    • Gastroenterology
    • Nursing

    Background:

    • Constipation is the most common nonmotor symptom in Parkinson disease (PD), potentially preceding motor symptoms by two decades.
    • The multifactorial causes of PD-related constipation can lead to severe health complications.
    • Early identification and management of constipation in PD are crucial for improving patient health and quality of life.

    Purpose of the Study:

    • To highlight the significance of constipation as an early indicator in Parkinson disease.
    • To outline current best practices for managing constipation in Parkinson disease patients.
    • To emphasize the role of nurses in the multidisciplinary care of Parkinson disease patients with constipation.

    Main Methods:

    • Review of current literature on Parkinson disease and constipation.
    • Analysis of nonpharmacological and pharmacological management strategies.
    • Discussion of nursing assessment, screening tools, and patient education.

    Main Results:

    • Constipation in PD is frequently underrecognized but significantly impacts patient well-being.
    • A combined approach of nonpharmacological (screening, assessment, education) and pharmacological interventions is the recommended management strategy.
    • Informed nurses are vital members of the healthcare team, enhancing patient care and outcomes.

    Conclusions:

    • Effective management of constipation in Parkinson disease requires a comprehensive, multidisciplinary approach.
    • Nurses play a critical role in the early detection and management of constipation in PD.
    • Optimizing constipation care in PD contributes to better overall patient health and quality of life.